Sánchez-Cuaxospa et al. have explored the expression levels of TLRs in AML patients and found lower expression levels of TLR1, TLR3, TLR4, TLR7 and TLR9 in the PBMCs of ALL patients compared with those from control patients. The gene discussed is TLR3; the disease is acute lymphoblastic leukemia.